Yubo International Biotech YBGJ Growth Metrics (2011-2026)

OTC YBGJ
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT
Reported Financials

Yubo International Biotech Quarterly Growth Metrics

Periods 50 quarters
Latest Mar 2026

Yubo International Biotech reported asset growth of -39.14% for the quarter ended Mar 2026. These growth metrics cover 50 quarters of results from Feb 2011 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
Assets Growth (1y)
14.29%-2.99%-14.63%-48.80%-52.67%-51.58%-48.82%-29.01%-26.70%-11.87%-13.13%-7.94%-24.71%-39.17%-42.37%-44.81%-39.14%
Assets Growth (3y)
-26.53%-25.47%-27.60%-30.58%-36.08%-36.21%-36.48%-28.82%-30.49%
Assets Growth (5y)
-28.90%
Assets (QoQ)
6.86%4.35%5.28%-2.65%-9.30%-8.17%-36.86%-10.00%-7.21%-2.93%-12.43%-7.08%11.57%-4.32%-7.20%-24.00%-9.85%-9.35%-11.13%-16.20%
Capital Expenditures Growth (1y)Capex Growth (1y)
-97.87%-107.10%-67.31%
Capital Expenditures Growth (3y)Capex Growth (3y)
-65.26%-13.66%
Capital Expenditures (QoQ)Capex (QoQ)
-70.03%-129.71%144.86%-46.71%-200.00%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
-91.74%-53.94%42.91%-33.79%189.70%-85.79%-94.11%-65.10%88.63%48.13%51.73%10.32%-82.86%35.27%36.00%14.93%6.23%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
-23.29%-54.06%-49.65%-36.59%-2.16%-34.21%-50.48%-23.80%-29.97%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
-39.33%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-37.12%-20.74%-56.29%-62.08%250.55%145.94%-79.75%65.92%-82.81%1.87%20.09%796.74%-86.50%4.34%-12.68%39.32%6.58%4.90%-26.21%28.78%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
97.87%107.10%-198.92%79.38%-23.11%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
59.50%41.40%-3.20%13.66%107.68%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
70.03%129.71%-144.86%46.71%200.00%-513.82%473.16%-67.43%1,491.69%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
105.08%-123.12%279.19%-982.69%-164.09%-768.08%-90.81%19.02%-911.97%-179.52%6,860.68%-67.05%-18.58%108.66%-201.62%86.20%47.16%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
30.91%-96.71%137.89%-144.66%-113.21%60.07%-104.09%42.84%-85.09%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
27.05%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
107.60%-140.44%-106.60%180.03%-134.59%413.34%-1,348.34%95.26%-368.41%103.32%-11,099.86%40.79%-29.38%182.60%-363.98%57.97%109.45%-1,069.14%64.14%-60.90%
EBITDA Margin Growth (1y)
-0.13M0.03M0.36M-1.83M0.16M-0.20M-1.02M
EBITDA Margin Growth (3y)
-0.21M
EBITDA Margin (QoQ)
0.02M-0.37M-0.23M0.45M0.18M-0.04M-2.42M2.44M-0.18M-0.86M
EBIT Growth (1y)
-32.01%-32.81%31.14%126.66%45.33%25.27%102.70%-599.91%-29.35%-28.09%-8,394.63%30.93%-14.14%46.92%41.79%20.10%38.10%
EBIT Growth (3y)
2.27%-8.33%-15.47%2.73%6.89%20.21%-9.18%-68.20%2.96%
EBIT Growth (5y)
7.99%
EBIT Margin Growth (1y)
-0.13M0.03M0.36M-1.95M0.16M-0.25M-1.15M
EBIT Margin Growth (3y)
-0.25M
EBIT Margin (QoQ)
0.02M-0.37M-0.24M0.45M0.18M-0.04M-2.55M2.57M-0.23M-0.94M
EBIT (QoQ)
15.62%6.50%-12.19%-49.13%15.10%51.52%143.43%-405.88%-16.03%101.75%-8,154.20%20.86%-14.90%-13.25%32.94%-30.79%46.57%-24.20%7.95%-1.33%
EBT Growth (1y)
-31.98%-32.82%31.19%126.69%45.30%25.27%102.64%-599.36%-29.32%-62.89%-9,968.95%31.79%-14.12%58.26%50.06%19.05%36.87%
EBT Growth (3y)
2.27%-17.37%-21.53%3.13%6.89%20.21%-9.21%-68.18%2.33%
EBT Growth (5y)
7.63%
EBT Margin Growth (1y)
-0.13M0.03M0.36M-1.95M0.16M-0.25M-1.15M
EBT Margin Growth (3y)
-0.25M
EBT Margin (QoQ)
0.02M-0.37M-0.24M0.45M0.18M-0.04M-2.55M2.57M-0.23M-0.94M
EBT (QoQ)
15.64%6.50%-12.19%-49.14%15.09%51.56%143.52%-405.64%-16.00%101.71%-8,321.55%20.85%-46.11%-3.79%43.18%-32.43%46.56%-24.20%7.90%-3.28%
EPS (Basic) Growth (1y)
-31.92%-32.79%29.57%125.96%46.05%26.29%102.62%-594.78%-19.15%-43.61%-9,329.99%44.02%-15.46%56.34%52.35%9.75%37.42%
EPS (Basic) Growth (3y)
5.35%-12.02%-19.40%10.41%9.46%22.68%-4.82%-65.10%4.87%
EPS (Basic) Growth (5y)
9.33%
EPS (Basic) (QoQ)
15.65%9.07%-18.05%-45.70%15.09%51.77%143.51%-402.83%-16.00%101.71%-8,321.55%27.08%-39.81%-10.11%50.13%-50.40%47.13%-20.16%5.55%-4.28%
EPS (Diluted) Growth (1y)
-31.98%-32.85%29.26%126.09%45.30%25.27%101.98%-3,836.93%-791.62%-7.47%-9,329.99%94.40%88.45%56.34%61.39%22.56%56.00%
EPS (Diluted) Growth (3y)
-86.01%-2.18%-8.90%18.28%17.42%29.48%11.00%-53.55%23.20%
EPS (Diluted) Growth (5y)
20.03%
EPS (Diluted) (QoQ)
15.65%9.03%-18.00%-45.77%15.09%51.56%143.52%-405.64%-16.00%101.28%-82,315.40%27.08%86.02%-10.11%50.13%-50.40%47.13%2.63%-0.02%14.55%
FCF Margin Growth (1y)
0.04M-0.10M-0.03M-1.06M-0.04M-0.15M-1.00M
FCF Margin Growth (3y)
-570.00
FCF Margin (QoQ)
-0.00M0.03M-0.04M0.05M-0.14M0.10M-1.07M1.07M-0.25M-0.75M
Free Cash Flow Growth (1y)FCF Growth (1y)
102.84%86.44%488.74%-743.74%-178.99%-1,808.76%-90.81%19.02%-969.90%-179.52%6,860.68%-67.05%-13.93%108.66%-201.62%86.20%47.98%
Free Cash Flow Growth (3y)FCF Growth (3y)
37.82%-93.43%235.19%-125.15%-126.56%87.78%-104.09%42.84%-85.09%
Free Cash Flow Growth (5y)FCF Growth (5y)
32.28%
Free Cash Flow (QoQ)FCF (QoQ)
95.94%115.87%-971.06%150.61%-119.38%788.99%-1,348.34%95.26%-368.41%103.32%-11,099.86%37.40%-22.38%182.60%-363.98%57.30%109.30%-1,069.14%64.14%-60.90%
Gross Margin Growth (1y)
-862.00-0.00M-0.00M-0.00M0.00M0.00M0.00M
Gross Margin Growth (3y)
0.00M
Gross Margin (QoQ)
-859.00-0.00M0.00M-757.00-0.00M-666.000.00M0.00M75.00-476.00
Gross Profit Growth (1y)
-97.38%-97.25%-86.88%-86.78%597.92%-84.87%3,484.19%-37.58%-95.39%-100.07%62,907.69%
Gross Profit Growth (3y)
-79.65%-25.99%-34.41%
Gross Profit (QoQ)
-32.51%-65.64%199.00%-96.22%-29.22%64.07%201.41%99.38%-98.47%38,779.32%-94.75%-85.27%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-966.20%94.74%13.55%103.61%-107.88%-284.26%-22,106.16%60.77%-58.47%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
-5.28%-9.23%-132.59%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
81.29%83.56%-207.14%100.69%-467.75%60.71%-58.70%
Net Cash Flow Growth (1y)NCF Growth (1y)
103.12%86.44%64.83%75.10%-178.99%-1,808.76%-67.18%1,020.65%-60.46%161.66%-706.03%-5.68%-129.78%238.38%-1,067.21%-5.49%106.12%
Net Cash Flow Growth (3y)NCF Growth (3y)
65.94%53.21%-74.12%60.85%-69.99%247.12%-193.25%116.92%30.56%
Net Cash Flow Growth (5y)NCF Growth (5y)
14.93%
Net Cash Flow (QoQ)NCF (QoQ)
95.55%115.87%-971.06%150.61%-119.38%292.89%-231.56%-60.58%-368.41%103.32%3,590.03%-127.99%280.00%-132.60%674.31%-168.18%365.07%-212.46%146.50%-95.59%
Net Income Growth (1y)
-31.98%-32.82%29.26%126.69%45.30%25.27%102.64%-599.36%-29.32%-62.89%-9,968.95%31.79%-14.12%58.26%50.06%19.05%36.87%
Net Income Growth (3y)
2.27%-17.37%-22.65%3.13%6.89%20.21%-9.21%-68.18%2.33%
Net Income Growth (5y)
7.63%
Net Income (QoQ)
15.64%9.05%-15.33%-49.14%15.09%51.56%143.52%-405.64%-16.00%101.71%-8,321.55%20.85%-46.11%-3.79%43.18%-32.43%46.56%-24.20%7.90%-3.28%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-31.98%-32.85%29.26%126.09%45.30%25.27%102.64%-599.36%-19.15%-43.61%-9,329.99%44.02%-15.46%56.34%52.35%9.75%37.42%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
4.90%-12.55%-19.95%9.99%9.05%22.33%-5.15%-65.38%4.87%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
9.08%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
15.65%9.03%-18.00%-45.77%15.09%51.56%143.52%-405.64%-16.00%101.71%-8,321.55%27.08%-39.81%-10.11%50.13%-50.40%47.13%-20.16%5.55%-4.28%
Net Margin Growth (1y)
-0.13M0.03M0.36M-1.95M0.16M-0.25M-1.06M
Net Margin Growth (3y)
-0.23M
Net Margin (QoQ)
0.02M-0.37M-0.24M0.45M0.18M-0.04M-2.55M2.57M-0.23M-0.85M
Operating Income Growth (1y)Op. Inc Growth (1y)
-32.01%-32.81%31.14%126.66%45.33%25.27%102.70%-599.91%-29.35%-28.09%-8,394.63%30.93%-14.14%46.92%41.79%20.10%38.10%
Operating Income Growth (3y)Op. Inc Growth (3y)
2.27%-8.33%-15.47%2.73%6.89%20.21%-9.18%-68.20%2.96%
Operating Income Growth (5y)Op. Inc Growth (5y)
7.99%
Operating Income (QoQ)Op. Inc (QoQ)
15.62%6.50%-12.19%-49.13%15.10%51.52%143.43%-405.88%-16.03%101.75%-8,154.20%20.86%-14.90%-13.25%32.94%-30.79%46.57%-24.20%7.95%-1.33%
Operating Margin Growth (1y)
-0.13M0.03M0.36M-1.95M0.16M-0.25M-1.15M
Operating Margin Growth (3y)
-0.25M
Operating Margin (QoQ)
0.02M-0.37M-0.24M0.45M0.18M-0.04M-2.55M2.57M-0.23M-0.94M
Profit After Tax Growth (1y)PAT Growth (1y)
-31.98%-32.82%31.19%126.69%45.30%25.27%102.64%-599.36%-29.32%-62.89%-9,968.95%31.79%-14.12%58.26%50.06%19.05%36.87%
Profit After Tax Growth (3y)PAT Growth (3y)
2.27%-17.37%-21.53%3.13%6.89%20.21%-9.21%-68.18%2.33%
Profit After Tax Growth (5y)PAT Growth (5y)
7.63%
Profit After Tax (QoQ)PAT (QoQ)
15.64%6.50%-12.19%-49.14%15.09%51.56%143.52%-405.64%-16.00%101.71%-8,321.55%20.85%-46.11%-3.79%43.18%-32.43%46.56%-24.20%7.90%-3.28%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
23.78%-7.04%-8.40%-4.23%-6.89%-14.61%-9.95%-39.15%-43.56%-44.01%-51.40%-45.12%-51.68%-57.03%-67.04%-79.10%-89.30%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
-13.36%-23.69%-26.26%-31.62%-36.67%-40.99%-47.55%-58.83%-69.21%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
-49.26%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
24.99%-2.94%0.53%1.49%-6.14%-4.35%5.11%-1.33%-13.92%0.87%-28.98%-8.48%-14.60%-12.44%-19.81%-19.41%-24.07%-32.83%-49.16%-58.72%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-0.00M-0.00M-542.00-527.00199.000.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M450.00
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
Return on Assets [ROA] (QoQ)ROA (QoQ)
-0.00M-685.00-269.00-518.00-151.00396.00-254.00208.000.00M-0.00M-0.00M-0.00M-0.00M261.00-0.00M-147.000.00M-817.00-66.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-0.03M-0.01M-0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-0.00M-0.00M-0.00M-0.02M0.01M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-0.00M-0.02M-0.31M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.13M0.03M0.36M-1.95M0.16M-0.25M-1.15M2.54M-0.75M-4.87M4.87M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.71M-5.09M-0.25M-0.90M
Return on Sales [ROS] (QoQ)ROS (QoQ)
0.02M-0.37M-0.24M0.45M0.18M-0.04M-2.55M2.57M-0.23M-0.94M1.14M-0.72M-4.35M-0.69M
Revenue Growth (1y)
-85.17%-79.98%929.48%-82.06%2,839.03%-66.50%-97.77%-100.08%68,727.78%
Revenue Growth (3y)
-25.99%-42.95%
Revenue (QoQ)
238.01%-95.42%-47.61%82.94%356.24%135.44%-99.09%29,865.73%-94.80%-84.35%
Total Debt Growth (1y)
Total Debt (QoQ)

Yubo International Biotech Growth Metrics API

Pull Yubo International Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=YBGJ&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY